Therefore, OPN could be a key regulator of inflammatory processes linked to obesity-induced adipose tissue inflammation and become a major target for treatment of adipose tissue inflammation-related disorders. The gene discussed is SPP1; the disease is obesity due to melanocortin 4 receptor deficiency.